Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

Merit Medical Systems, Inc. manufactures and markets products used in diagnostic and interventional cardiology and radiology procedures. The Company"s primary products include inflation devices, guide wires, thrombolytic catheters and fluid dispensing systems, and angiography accessories, among others. Merit"s products are sold worldwide.
Website: merit.com


  • Good financial results growth rate 14.3% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (16.6%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield -2.7% (LTM)
  • Share price is 31.2% higher than minimum and 25.2% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (18.5x vs 23.9x)
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $5.6 mln (-0.110% of cap.)

Key Financials (Download financials)

Ticker: MMSI
Share price, USD:  (0.0%)82.54
year average price 90.45  


year start price 109.50 2025-02-08

max close price 109.96 2025-02-10

min close price 78.99 2025-10-10

current price 82.54 2026-02-07
Common stocks: 59 245 000

Dividend Yield:  0.0%
FCF Yield LTM: -2.7%
EV / LTM EBITDA: 18.5x
EV / EBITDA annualized: 18.0x
Last revenue growth (y/y):  +12.9%
Last growth of EBITDA (y/y):  +15.6%
Historical revenue growth:  +9.2%
Historical growth of EBITDA:  +24.0%
EV / Sales: 3.6x
Margin (EBITDA LTM / Revenue): 19.4%

Target EV / EBITDA (hist percentile): 23.9x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 4 890
Net Debt ($m): 430
EV (Enterprise Value): 5 320
EBITDA LTM (млн $): 287
EV / LTM EBITDA: 18.5x
Price to Book: 3.2x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-26zacks.com

Why Merit Medical (MMSI) is Poised to Beat Earnings Estimates Again

2026-01-13seekingalpha.com

Merit Medical Systems, Inc. (MMSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-23zacks.com

Here's Why You Should Retain Merit Medical Stock in Your Portfolio Now

2025-12-18zacks.com

Why Merit Medical (MMSI) is a Top Momentum Stock for the Long-Term

2025-11-21zacks.com

Merit Medical (MMSI) Upgraded to Buy: What Does It Mean for the Stock?

2025-10-30seekingalpha.com

Merit Medical Systems, Inc. (MMSI) Q3 2025 Earnings Call Transcript

2025-10-30zacks.com

Merit Medical (MMSI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

2025-10-22zacks.com

MMSI or SAUHY: Which Is the Better Value Stock Right Now?

2025-09-30zacks.com

Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term

2025-09-15zacks.com

MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982
fillingDate 2025-10-30 2025-07-30 2024-10-30 2024-08-01 2024-04-30 2023-10-26 2023-07-28 2023-04-28 2022-10-28
acceptedDate 2025-10-30 16:12:21 2025-07-30 16:19:00 2025-02-25 16:16:03 2024-10-30 16:25:14 2024-08-01 16:45:46 2024-04-30 16:15:29 2024-02-28 16:16:26 2023-10-26 16:25:39 2023-07-28 16:15:53 2023-04-28 13:38:29 2023-02-24 16:45:31 2022-10-28 15:04:29 2022-03-01 12:56:03 2021-03-01 12:51:36
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 384M 382M 1 357M 340M 338M 324M 1 257M 315M 320M 298M 1 151M 287M 1 075M 964M
costOfRevenue 198M 198M 713M 182M 177M 172M 673M 173M 167M 159M 632M 159M 589M 563M
grossProfit 186M 184M 643M 158M 160M 152M 584M 142M 153M 138M 519M 129M 485M 401M
grossProfitRatio 0.485 0.482 0.464 0.475 0.469 0.451 0.477 0.465 0.448
researchAndDevelopmentExpenses 24M 24M 84M 21M 20M 21M 83M 20M 20M 21M 76M 19M 71M 58M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 120M 113M 377M 100M 95M 94M 374M 87M 101M 90M 343M 90M 336M 298M
otherExpenses 32 000 143 000 27M 103 000 15 000 -804 000 4M -255 000 -451 000 997 000 14M 0 17M 47M
operatingExpenses 144M 138M 488M 120M 115M 116M 459M 107M 121M 111M 432M 109M 424M 403M
costAndExpenses 342M 336M 1 201M 303M 292M 288M 1 133M 280M 288M 271M 1 063M 268M 1 014M 965M
interestIncome 4M 4M 26M 7M 8M 7M 2M 181 000 221 000 131 000 439 000 116 000 769 000 604 000
interestExpense 7M 7M 31M 8M 8M 8M 16M 5M 4M 2M 6M 2M 5M 10M
depreciationAndAmortization 34M 34M 115M 29M 27M 27M 101M 27M 28M 25M 92M 24M 96M 107M
ebitda 80M 84M 274M 74M 81M 69M 229M 62M 57M 51M 181M 43M 155M 104M
ebitdaratio 0.207 0.22 0.217 0.215 0.213 0.198 0.177 0.172 0.148
operatingIncome 43M 47M 156M 37M 45M 36M 124M 35M 29M 26M 88M 19M 61M -2M
operatingIncomeRatio 0.111 0.123 0.11 0.135 0.111 0.111 0.09 0.089 0.065
totalOtherIncomeExpensesNet -4M -4M -6M -604 000 -103 000 -687 000 -12M -817 000 -4M -883 000 -5M -1M -7M -12M
incomeBeforeTax 39M 43M 150M 37M 46M 34M 112M 30M 25M 26M 83M 18M 54M -13M
incomeBeforeTaxRatio 0.1 0.113 0.108 0.136 0.106 0.096 0.078 0.086 0.061
incomeTaxExpense 11M 11M 30M 8M 10M 6M 18M 4M 5M 5M 8M 2M 5M -3M
netIncome 28M 33M 120M 28M 36M 28M 94M 26M 20M 21M 75M 15M 48M -10M
netIncomeRatio 0.072 0.085 0.084 0.106 0.087 0.082 0.063 0.07 0.053
eps 0.47 0.55 2.07 0.49 0.61 0.49 1.64 0.45 0.35 0.36 1.31 0.27 0.86 -0.18
epsdiluted 0.46 0.54 0.48 0.61 0.48 0.44 0.35 0.36 0.27
weightedAverageShsOut 59M 59M 58M 58M 58M 58M 58M 58M 58M 57M 57M 57M 56M 55M
weightedAverageShsOutDil 60M 61M 59M 60M 59M 59M 58M 58M 58M 58M 58M 58M 57M 55M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-28 2023-02-24 2022-03-01 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -5M -13M -6M -4M -9M
ebit 159M 128M 89M 59M -3M
nonOperatingIncomeExcludingInterest -4M -4M -1M 2M 2M
netIncomeFromContinuingOperations 120M 94M 75M 48M -10M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 120M 94M 75M 48M -10M
epsDiluted 2.03 1.62 1.29 0.84 -0.18

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982
fillingDate 2025-10-30 2025-07-30 2024-10-30 2024-08-01 2024-04-30 2023-10-26 2023-07-28 2023-04-28 2022-10-28
acceptedDate 2025-10-30 16:12:21 2025-07-30 16:19:00 2025-02-25 16:16:03 2024-10-30 16:25:14 2024-08-01 16:45:46 2024-04-30 16:15:29 2024-02-28 16:16:26 2023-10-26 16:25:39 2023-07-28 16:15:53 2023-04-28 13:38:29 2023-02-24 16:45:31 2022-10-28 15:04:29 2022-03-01 12:56:03 2021-03-01 12:51:36
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 392M 344M 377M 523M 639M 582M 587M 59M 72M 58M 58M 51M 68M 57M
shortTermInvestments 0 0 0 2M 254 000 1M 2M 2M 0 0 0 0 0 0
cashAndShortTermInvestments 392M 344M 377M 523M 639M 582M 589M 59M 72M 58M 58M 51M 68M 57M
netReceivables 232M 224M 209M 213M 197M 192M 189M 191M 188M 186M 178M 171M 173M 158M
inventory 327M 323M 306M 311M 298M 303M 304M 304M 306M 290M 266M 247M 222M 198M
otherCurrentAssets 35M 32M 29M 31M 28M 24M 22M 28M 25M 20M 22M 31M 16M 13M
totalCurrentAssets 986M 923M 924M 1 078M 1 163M 1 105M 1 108M 585M 595M 557M 529M 500M 482M 430M
propertyPlantEquipmentNet 507M 499M 452M 459M 456M 456M 447M 447M 447M 450M 448M 441M 438M 461M
goodwill 507M 505M 464M 399M 381M 382M 382M 381M 382M 360M 360M 358M 362M 364M
intangibleAssets 538M 562M 498M 372M 303M 317M 326M 340M 355M 264M 276M 284M 319M 368M
goodwillAndIntangibleAssets 1 046M 1 067M 962M 772M 685M 699M 708M 721M 737M 624M 636M 642M 681M 731M
longTermInvestments 0 48M 23M 32M 32M -6M 19M 698 000 4M 0 16M 0 15M 12M
taxAssets 16M 16M 16M 7M 7M 7M 7M 6M 6M 7M 7M 5M 6M 5M
otherNonCurrentAssets 77M 33M 43M 30M 30M 64M 36M 48M 49M 46M 29M 44M 27M 26M
totalNonCurrentAssets 1 645M 1 663M 1 495M 1 300M 1 209M 1 221M 1 217M 1 223M 1 243M 1 127M 1 135M 1 133M 1 166M 1 235M
otherAssets 0 0 0 1 0 0 0 0 0 0 0 0 0 0
totalAssets 2 631M 2 586M 2 419M 2 378M 2 372M 2 326M 2 325M 1 809M 1 838M 1 684M 1 664M 1 633M 1 648M 1 664M
accountPayables 65M 69M 69M 61M 56M 48M 66M 49M 62M 66M 69M 63M 56M 50M
shortTermDebt 11M 10M 0 23M 23M 12M 0 15M 15M 22M 22M 22M 19M 20M
taxPayables 8M 6M 3M 2M 1M 9M 5M 4M 2M 9M 7M 4M 3M 3M
deferredRevenue 0 0 0 0 1M -12M 0 -49M -62M 0 0 0 0 0
otherCurrentLiabilities 147M 140M 134M 116M 106M 135M 53M 172M 175M 128M 42M 128M 77M 48M
totalCurrentLiabilities 230M 226M 216M 201M 186M 183M 204M 187M 190M 216M 221M 213M 236M 185M
longTermDebt 811M 810M 730M 808M 859M 860M 823M 340M 392M 244M 187M 265M 234M 344M
deferredRevenueNonCurrent 1M 1M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M 2M
deferredTaxLiabilitiesNonCurrent 27M 27M 240 000 6M 6M 6M 6M 18M 18M 18M 18M 31M 32M 33M
otherNonCurrentLiabilities 32M 34M 37M 39M 37M 35M 33M 32M 32M 32M 32M 246M 43M 71M
totalNonCurrentLiabilities 871M 872M 823M 854M 903M 903M 920M 391M 444M 297M 299M 331M 372M 521M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 88M 89M 65M 69M 70M 73M 68M 69M 68M 69M 71M 70M 72M 84M
totalLiabilities 1 102M 1 098M 1 039M 1 055M 1 089M 1 086M 1 123M 579M 634M 512M 520M 544M 608M 706M
preferredStock 0 0 0 0 0 1 0 0 0 0 0 0 0 0
commonStock 747M 735M 703M 669M 659M 649M 638M 695M 692M 681M 675M 658M 642M 606M
retainedEarnings 786M 758M 696M 668M 639M 603M 575M 548M 522M 501M 481M 447M 406M 358M
accumulatedOtherComprehensiveIncomeLoss -4M -5M -19M -13M -15M -12M -11M -13M -10M -11M -12M -17M -8M -5M
othertotalStockholdersEquity 0 0 0 0 -1 0 0 0 0
totalStockholdersEquity 1 529M 1 488M 1 379M 1 323M 1 282M 1 240M 1 202M 1 230M 1 204M 1 172M 1 144M 1 089M 1 040M 959M
totalEquity 1 529M 1 488M 1 379M 1 323M 1 282M 1 240M 1 202M 1 230M 1 204M 1 172M 1 144M 1 089M 1 040M 959M
totalLiabilitiesAndStockholdersEquity 2 631M 2 586M 2 378M 2 372M 2 326M 1 809M 1 838M 1 684M 1 633M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 2 631M 2 586M 2 419M 2 378M 2 372M 2 326M 2 325M 1 809M 1 838M 1 684M 1 664M 1 633M 1 648M 1 664M
totalInvestments 0 48M 23M 32M 32M 1M 21M 698 000 4M 0 16M 0 15M 12M
totalDebt 821M 821M 795M 819M 871M 873M 891M 355M 407M 266M 280M 287M 326M 448M
netDebt 429M 477M 418M 296M 232M 291M 304M 297M 335M 209M 221M 235M 258M 391M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-28 2023-02-24 2022-03-01 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 190M 178M 165M 152M 147M
otherReceivables 19M 11M 14M 21M 11M
prepaids 3M 4M 4M 4M 4M
totalPayables 72M 71M 86M 69M 62M
otherPayables 3M 5M 18M 14M 12M
accruedExpenses 0 67M 59M 60M 41M
capitalLeaseObligationsCurrent 10M 12M 11M 11M 13M
capitalLeaseObligationsNonCurrent 55M 56M 60M 62M 71M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 0 0 0 0 0
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI MMSI
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982 856 982
fillingDate 2025-10-30 2025-07-30 2024-10-30 2024-08-01 2024-04-30 2023-10-26 2023-07-28 2023-04-28 2022-10-28
acceptedDate 2025-10-30 16:12:21 2025-07-30 16:19:00 2025-02-25 16:16:03 2024-10-30 16:25:14 2024-08-01 16:45:46 2024-04-30 16:15:29 2024-02-28 16:16:26 2023-10-26 16:25:39 2023-07-28 16:15:53 2023-04-28 13:38:29 2023-02-24 16:45:31 2022-10-28 15:04:29 2022-03-01 12:56:03 2021-03-01 12:51:36
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 28M 33M 120M 28M 36M 28M 94M 26M 20M 21M 75M 15M 48M -10M
depreciationAndAmortization 34M 34M 115M 29M 27M 27M 101M 27M 25M 23M 92M 23M 96M 107M
deferredIncomeTax 0 0 -15M 0 0 0 -13M 133 000 121 000 0 -15M 0 -5M -11M
stockBasedCompensation 14M 11M 28M 7M 7M 5M 21M 6M 6M 4M 18M 5M 16M 14M
changeInWorkingCapital -2M 4M -37M -19M 1M -26M -70M -8M -41M -34M -71M -9M -18M 34M
accountsReceivables -4M -2M -22M -11M -3M -4M 0 2M -1M -5M -15M 409 000 -9M 10M
inventory -3M -1M -2M -6M 4M -382 000 0 1M -13M -23M -48M -16M -25M 29M
accountsPayables -269 000 -756 000 -2M 607 000 7M -14M -7M -13M -4M 2M 13M 6M 6M 333 000
otherWorkingCapital 5M 9M -11M -3M 470 000 1M -63M 2M -23M -9M -21M 800 000 10M -6M
otherNonCashItems 2M 2M 9M 2M -3M 1M 11M 902 000 8M 853 000 16M 1M 9M 31M
netCashProvidedByOperatingActivities 75M 83M 221M 47M 69M 36M 145M 51M 17M 15M 114M 35M 147M 165M
investmentsInPropertyPlantAndEquipment -23M 22M 0 -10M -11M -13M -37M -9M -6M -13M -45M -17M -28M -49M
acquisitionsNet -279 000 -122M -320M -105M -5M -3M -138M 71 000 -136M -2M -8M 0 -7M -10M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites -315 000 -43M -497 000 -712 999 -6M -729 000 -1M -71 000 -17M
netCashUsedForInvestingActivites -24M -143M -116M -16M -22M -9M -143M -15M -17M
debtRepayment 0 0 -52M 0 -24M -73M -268M -50M -74M
commonStockIssued 2M 7M 4M 3M 8M 2M 5M 4M 3M
commonStockRepurchased 0 0 0 0 0 -2M 0 -4M 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites -3M -3M -67 000 -64 000 -2M 24M 404M 46M 43M
netCashUsedProvidedByFinancingActivities -365 000 4M -48M 3M -18M -55M 142M -497 000 -27M
effectOfForexChangesOnCash 94 000 2M -3M 2M -431 000 -1M -484 000 -684 000 -2M 376 000 -4M -3M -801 000 2M
netChangeInCash 51M -54M -210M -113M 55M -5M 529M -13M 14M -432 000 -7M -12M 11M 13M
cashAtEndOfPeriod 395M 344M 379M 525M 639M 584M 589M 61M 74M 60M 61M 54M 68M 57M
cashAtBeginningOfPeriod 344M 398M 589M 639M 584M 589M 61M 74M 60M 61M 68M 65M 57M 44M
operatingCashFlow 75M 83M 221M 47M 69M 36M 145M 51M 17M 15M 114M 35M 147M 165M
capitalExpenditure -23M 22M -38M -10M -11M -13M -37M -9M -6M -13M -45M -17M -28M -49M
freeCashFlow 52M 105M 183M 37M 57M 24M 108M 42M 12M 2M 69M 19M 119M 116M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-25 2024-02-28 2023-02-24 2022-03-01 2021-03-01
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities -48M -799 000 -4M -2M 292 000
netCashProvidedByInvestingActivities -369M -175M -57M -37M -59M
netDebtIssuance -99M 620M -45M -109M -88M
longTermNetDebtIssuance -99M 620M -45M -109M -88M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 41M 16M 20M 21M 7M
netCommonStockIssuance 41M 16M 20M 21M 7M
commonStockIssuance 41M 16M 20M 21M 7M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -2M -76M -35M -11M -14M
netCashProvidedByFinancingActivities -60M 559M -60M -98M -96M
incomeTaxesPaid 45M 32M 17M 9M 9M
interestPaid 23M 14M 6M 5M 10M

Earning call transcript

2025 q3
2025-10-30 ET (fiscal 2025 q3)
2025 q2
2025-07-31 ET (fiscal 2025 q2)
2025 q1
2025-04-25 ET (fiscal 2025 q1)
2024 q4
2025-02-25 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-08-03 ET (fiscal 2024 q2)
2024 q1
2024-04-30 ET (fiscal 2024 q1)
2023 q4
2024-02-28 ET (fiscal 2023 q4)
2023 q3
2023-10-26 ET (fiscal 2023 q3)
2023 q2
2023-07-26 ET (fiscal 2023 q2)
2023 q1
2023-04-26 ET (fiscal 2023 q1)
2022 q4
2023-02-22 ET (fiscal 2022 q4)
2022 q3
2022-10-26 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-04-27 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-10-30 20:12 ET
Merit Medical Systems reported for 2025 q3
SEC form 8
2025-10-30 20:08 ET
Merit Medical Systems published news for 2025 q3
SEC form 8
2025-10-30 20:08 ET
Merit Medical Systems published news for 2025 q3
SEC form 8
2025-10-30 20:08 ET
Merit Medical Systems published news for 2025 q3
SEC form 10
2025-07-30 20:19 ET
Merit Medical Systems reported for 2025 q2
SEC form 8
2025-07-30 20:15 ET
Merit Medical Systems published news for 2025 q2
SEC form 8
2025-07-30 20:15 ET
Merit Medical Systems published news for 2025 q2
SEC form 8
2025-07-30 20:15 ET
Merit Medical Systems published news for 2025 q2
SEC form 8
2025-07-11 20:07 ET
Merit Medical Systems published news for 2025 q2
SEC form 8
2025-07-11 20:07 ET
Merit Medical Systems published news for 2025 q2
SEC form 8
2025-05-19 20:26 ET
Merit Medical Systems published news for 2025 q1
SEC form 10
2025-04-24 20:24 ET
Merit Medical Systems reported for 2025 q1
SEC form 8
2025-04-24 20:20 ET
Merit Medical Systems published news for 2025 q1
SEC form 8
2025-04-24 20:20 ET
Merit Medical Systems reported for 2025 q1
SEC form 8
2025-04-24 20:20 ET
Merit Medical Systems published news for 2025 q1
SEC form 10
2025-04-24 00:00 ET
Merit Medical Systems published news for 2025 q1
SEC form 10
2025-02-25 21:16 ET
Merit Medical Systems published news for 2024 q4
SEC form 10
2025-02-25 00:00 ET
Merit Medical Systems reported for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Merit Medical Systems published news for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Merit Medical Systems published news for 2024 q4
SEC form 8
2025-02-25 00:00 ET
Merit Medical Systems published news for 2024 q4
SEC form 8
2025-01-28 21:35 ET
Merit Medical Systems published news for 2024 q4
SEC form 8
2025-01-28 21:35 ET
Merit Medical Systems published news for 2024 q4
SEC form 8
2025-01-14 00:00 ET
Merit Medical Systems published news for 2024 q4
SEC form 8
2025-01-14 00:00 ET
Merit Medical Systems published news for 2024 q4
SEC form 10
2024-10-30 16:25 ET
Merit Medical Systems reported for 2024 q3
SEC form 8
2024-10-30 16:14 ET
Merit Medical Systems published news for 2024 q3
SEC form 8
2024-10-30 16:14 ET
Merit Medical Systems published news for 2024 q3
SEC form 8
2024-10-30 16:14 ET
Merit Medical Systems published news for 2024 q3
SEC form 10
2024-10-30 00:00 ET
Merit Medical Systems published news for 2024 q3
SEC form 10
2024-08-01 16:45 ET
Merit Medical Systems reported for 2024 q2
SEC form 8
2024-08-01 16:39 ET
Merit Medical Systems published news for 2024 q2
SEC form 8
2024-08-01 16:39 ET
Merit Medical Systems published news for 2024 q2
SEC form 8
2024-08-01 16:39 ET
Merit Medical Systems published news for 2024 q2
SEC form 8
2024-08-01 16:39 ET
Merit Medical Systems published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
Merit Medical Systems published news for 2024 q2
SEC form 10
2024-04-30 16:15 ET
Merit Medical Systems reported for 2024 q1
SEC form 8
2024-04-30 16:11 ET
Merit Medical Systems published news for 2024 q1
SEC form 8
2024-04-30 16:11 ET
Merit Medical Systems published news for 2024 q1
SEC form 8
2024-04-30 16:11 ET
Merit Medical Systems published news for 2024 q1
SEC form 10
2024-04-30 00:00 ET
Merit Medical Systems published news for 2024 q1
SEC form 10
2024-02-28 17:07 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems reported for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-02-28 16:16 ET
Merit Medical Systems published news for 2023 q4
SEC form 10
2024-02-28 00:00 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Merit Medical Systems published news for 2023 q4
SEC form 8
2024-01-08 00:00 ET
Merit Medical Systems published news for 2023 q4
SEC form 10
2023-10-26 16:25 ET
Merit Medical Systems published news for 2023 q3
SEC form 8
2023-10-26 16:16 ET
Merit Medical Systems reported for 2023 q3
SEC form 10
2023-10-26 00:00 ET
Merit Medical Systems published news for 2023 q3
SEC form 10
2023-07-28 00:00 ET
Merit Medical Systems published news for 2023 q2
SEC form 6
2023-07-25 16:46 ET
Merit Medical Systems reported for 2023 q2
SEC form 8
2023-07-25 00:00 ET
Merit Medical Systems published news for 2023 q2
SEC form 6
2023-06-29 14:09 ET
Merit Medical Systems published news for 2023 q1
SEC form 6
2023-06-08 16:37 ET
Merit Medical Systems published news for 2023 q1
SEC form 6
2023-06-07 18:14 ET
Merit Medical Systems published news for 2023 q1
SEC form 10
2023-04-28 00:00 ET
Merit Medical Systems published news for 2023 q1
SEC form 8
2023-04-26 00:00 ET
Merit Medical Systems reported for 2023 q1
SEC form 6
2023-02-28 16:23 ET
Merit Medical Systems published news for 2022 q4
SEC form 10
2023-02-24 16:45 ET
Merit Medical Systems reported for 2022 q4
SEC form 10
2023-02-24 00:00 ET
Merit Medical Systems reported for 2022 q4
SEC form 6
2023-02-22 16:55 ET
Merit Medical Systems published news for 2022 q4
SEC form 8
2023-02-22 00:00 ET
Merit Medical Systems reported for 2022 q4
SEC form 6
2022-11-02 16:21 ET
Merit Medical Systems published news for 2022 q3
SEC form 10
2022-10-28 15:04 ET
Merit Medical Systems reported for 2022 q3
SEC form 10
2022-10-28 00:00 ET
Merit Medical Systems reported for 2022 q3
SEC form 6
2022-10-26 16:41 ET
Merit Medical Systems published news for 2022 q3
SEC form 8
2022-10-26 00:00 ET
Merit Medical Systems reported for 2022 q3
SEC form 6
2022-09-01 16:04 ET
Merit Medical Systems published news for 2022 q2
SEC form 10
2022-08-05 16:18 ET
Merit Medical Systems reported for 2022 q2
SEC form 10
2022-08-05 00:00 ET
Merit Medical Systems reported for 2022 q2
SEC form 6
2022-07-27 16:47 ET
Merit Medical Systems published news for 2022 q2
SEC form 8
2022-07-27 00:00 ET
Merit Medical Systems reported for 2022 q2
SEC form 6
2022-06-29 12:11 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-06-02 21:59 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-05-26 17:59 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-05-26 17:57 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-05-25 15:57 ET
Merit Medical Systems published news for 2022 q1
SEC form 10
2022-05-06 13:54 ET
Merit Medical Systems reported for 2022 q1
SEC form 10
2022-05-06 00:00 ET
Merit Medical Systems reported for 2022 q1
SEC form 6
2022-04-29 18:58 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-04-27 16:46 ET
Merit Medical Systems published news for 2022 q1
SEC form 8
2022-04-27 00:00 ET
Merit Medical Systems reported for 2022 q1
SEC form 6
2022-04-22 17:00 ET
Merit Medical Systems published news for 2022 q1
SEC form 6
2022-04-07 16:16 ET
Merit Medical Systems published news for 2022 q1
SEC form 10
2022-03-01 12:56 ET
Merit Medical Systems published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Merit Medical Systems published news for 2021 q4
SEC form 6
2022-02-24 16:44 ET
Merit Medical Systems published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
Merit Medical Systems published news for 2021 q4
SEC form 6
2021-11-24 12:14 ET
Merit Medical Systems published news for 2021 q3
SEC form 10
2021-11-05 16:53 ET
Merit Medical Systems published news for 2021 q3
SEC form 10
2021-11-05 00:00 ET
Merit Medical Systems published news for 2021 q3
SEC form 6
2021-10-28 16:40 ET
Merit Medical Systems published news for 2021 q3
SEC form 8
2021-10-28 00:00 ET
Merit Medical Systems published news for 2021 q3
SEC form 6
2021-10-22 16:36 ET
Merit Medical Systems published news for 2021 q3
SEC form 10
2021-08-06 15:42 ET
Merit Medical Systems published news for 2021 q2
SEC form 10
2021-08-06 00:00 ET
Merit Medical Systems published news for 2021 q2
SEC form 6
2021-07-29 16:45 ET
Merit Medical Systems published news for 2021 q2
SEC form 8
2021-07-29 00:00 ET
Merit Medical Systems published news for 2021 q2
SEC form 6
2021-06-29 13:48 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-06-23 16:40 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-06-21 19:07 ET
Merit Medical Systems published news for 2021 q1
SEC form 10
2021-05-07 13:48 ET
Merit Medical Systems published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-04-30 16:40 ET
Merit Medical Systems published news for 2021 q1
SEC form 6
2021-04-29 16:45 ET
Merit Medical Systems published news for 2021 q1
SEC form 8
2021-04-29 00:00 ET
Merit Medical Systems published news for 2021 q1
SEC form 10
2021-03-01 12:51 ET
Merit Medical Systems published news for 2020 q4
SEC form 6
2021-02-24 16:39 ET
Merit Medical Systems published news for 2020 q4
SEC form 6
2020-12-21 18:57 ET
Merit Medical Systems published news for 2020 q3
SEC form 6
2020-11-10 16:47 ET
Merit Medical Systems published news for 2020 q3
SEC form 10
2020-11-05 15:55 ET
Merit Medical Systems published news for 2020 q3
SEC form 6
2020-10-28 16:34 ET
Merit Medical Systems published news for 2020 q3
SEC form 6
2020-10-16 17:28 ET
Merit Medical Systems published news for 2020 q3